These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34331588)

  • 1. Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities.
    Trudzinski FC; Kellerer C; Jörres RA; Alter P; Lutter JI; Trinkmann F; Herth FJF; Frankenberger M; Watz H; Vogelmeier CF; Kauczor HU; Welte T; Behr J; Bals R; Kahnert K
    Clin Res Cardiol; 2023 Feb; 112(2):177-186. PubMed ID: 34331588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET.
    Kellerer C; Jörres RA; Schneider A; Alter P; Kauczor HU; Jobst B; Biederer J; Bals R; Watz H; Behr J; Kauffmann-Guerrero D; Lutter J; Hapfelmeier A; Magnussen H; Trudzinski FC; Welte T; Vogelmeier CF; Kahnert K
    Respir Res; 2021 Sep; 22(1):242. PubMed ID: 34503520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAT score single item analysis in patients with COPD: Results from COSYCONET.
    Marietta von Siemens S; Alter P; Lutter JI; Kauczor HU; Jobst B; Bals R; Trudzinski FC; Söhler S; Behr J; Watz H; Waschki B; Bewig B; Jones PW; Welte T; Vogelmeier CF; Jörres RA; Kahnert K; ;
    Respir Med; 2019 Nov; 159():105810. PubMed ID: 31739262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.
    Frantzi N; Nguyen XP; Herr C; Alter P; Söhler S; Soriano D; Watz H; Waschki B; Trinkmann F; Eichenlaub M; Trudzinski FC; Michels-Zetsche JD; Omlor A; Seiler F; Moneke I; Biertz F; Rohde G; Stolz D; Welte T; Kauczor HU; Kahnert K; Jörres RA; Vogelmeier CF; Bals R; Fähndrich S;
    Respir Res; 2024 May; 25(1):207. PubMed ID: 38750572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort.
    Alter P; Mayerhofer BA; Kahnert K; Watz H; Waschki B; Andreas S; Biertz F; Bals R; Vogelmeier CF; Jörres RA
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2163-2172. PubMed ID: 31571852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of frailty in primary care patients with COPD: the Greek UNLOCK study.
    Ierodiakonou D; Kampouraki M; Poulonirakis I; Papadokostakis P; Lintovoi E; Karanassos D; Maltezis K; Chorti M; Petrovitsos E; Dimopoulou S; Hamind S; Gialamas I; Athanasiou P; Bempi V; Lambraki I; Tsiligianni I
    BMC Pulm Med; 2019 Mar; 19(1):63. PubMed ID: 30876423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study.
    von Siemens SM; Jörres RA; Behr J; Alter P; Lutter J; Lucke T; Söhler S; Welte T; Watz H; Vogelmeier CF; Trudzinski F; Rief W; Herbig B; Kahnert K;
    Respir Res; 2019 Feb; 20(1):30. PubMed ID: 30744630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients.
    Cheng SL; Lin CH; Wang CC; Chan MC; Hsu JY; Hang LW; Perng DW; Yu CJ; Wang HC;
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):429-435. PubMed ID: 30150099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease.
    Chang CH; Chuang LP; Lin SW; Lee CS; Tsai YH; Wei YF; Cheng SL; Hsu JY; Kuo PH; Yu CJ; Chen NH
    BMC Pulm Med; 2016 Aug; 16(1):118. PubMed ID: 27501837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of comorbid heart disease on dyspnea and health status in patients with COPD - a cohort study.
    Giezeman M; Hasselgren M; Lisspers K; Ställberg B; Montgomery S; Janson C; Sundh J
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3857-3865. PubMed ID: 30568437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of CAT (COPD Assessment Test) scores in a population of patients with COPD in central and Eastern Europe: The POPE study.
    Miravitlles M; Koblizek V; Esquinas C; Milenkovic B; Barczyk A; Tkacova R; Somfay A; Zykov K; Tudoric N; Kostov K; Zbozinkova Z; Svoboda M; Sorli J; Krams A; Valipour A
    Respir Med; 2019 Apr; 150():141-148. PubMed ID: 30961941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The revised GOLD 2017 COPD categorization in relation to comorbidities.
    Kahnert K; Alter P; Young D; Lucke T; Heinrich J; Huber RM; Behr J; Wacker M; Biertz F; Watz H; Bals R; Welte T; Wirtz H; Herth F; Vestbo J; Wouters EF; Vogelmeier CF; Jörres RA
    Respir Med; 2018 Jan; 134():79-85. PubMed ID: 29413512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.
    Zhou Z; Zhou A; Peng Y; Duan J; Zeng Y; Zhao Y; Cheng W; Chen P
    Respiration; 2020; 99(7):606-616. PubMed ID: 32659763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET.
    Trudzinski FC; Jörres RA; Alter P; Walter J; Watz H; Koch A; John M; Lommatzsch M; Vogelmeier CF; Kauczor HU; Welte T; Behr J; Tufman A; Bals R; Herth FJF; Kahnert K;
    Sci Rep; 2022 May; 12(1):8790. PubMed ID: 35610473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies.
    Wacker ME; Jörres RA; Karch A; Koch A; Heinrich J; Karrasch S; Schulz H; Peters A; Gläser S; Ewert R; Baumeister SE; Vogelmeier C; Leidl R; Holle R;
    Respir Res; 2016 Jul; 17(1):81. PubMed ID: 27405652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities.
    Wacker ME; Jörres RA; Karch A; Wilke S; Heinrich J; Karrasch S; Koch A; Schulz H; Watz H; Leidl R; Vogelmeier C; Holle R;
    BMC Pulm Med; 2016 May; 16(1):70. PubMed ID: 27160582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of the COPD assessment test: longitudinal data from the COPD History Assessment in Spain (CHAIN) cohort.
    de Torres JP; Marin JM; Martinez-Gonzalez C; de Lucas-Ramos P; Mir-Viladrich I; Cosio B; Peces-Barba G; Calle-Rubio M; Solanes-García I; Agüero Balbin R; de Diego-Damia A; Feu-Collado N; Alfageme Michavila I; Irigaray R; Balcells E; Llunell Casanovas A; Galdiz Iturri JB; Marín Royo M; Soler-Cataluña JJ; Lopez-Campos JL; Soriano JB; Casanova C;
    Chest; 2014 Jul; 146(1):111-122. PubMed ID: 24522636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study.
    Ozaltin B; Chapman R; Arfeen MQU; Fitzpatick N; Hemingway H; Direk K; Jacob J
    Respir Res; 2024 Jun; 25(1):249. PubMed ID: 38898447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.